In vivo Nanosensors for Diagnostics (IVN:Dx)

Award Notice Posted

Solicitation number
DARPA-BAA-12-33
Agency
Awarded
to Teledyne Flir Defense, Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
HR001113C0004 Federal contract award
PSC
Not on record

Notice details come from SAM.gov. Updated .

Notice text

The specific objective of the In vivo Nanoplatforms for Diagnostics (IVN:Dx) thrust of the In vivo Nanoplatforms (IVN) program is to develop biocompatible nanosensors that provide continuous, noninvasive, and highly accurate measurement of a variety of conditions and substances within the living tissue of animals, plants, and insects using non-toxic materials with limited immunogenicity. These sensors will permit qualitative and quantitative assessment over large concentration ranges of both small (e.g., glucose, lactate, and urea) and large molecules (e.g., proteins, oligonucleotides, infectious agents, and chemical/biological threat agents) in the organism and environment through optical, electronic, thermal or magnetic mechanisms.

See the attached DARPA-BAA-12-33 document.

Files

Notice history

Notice Type Posted
In vivo Nanosensors for Diagnostics (IVN:Dx) Latest Award Notice
This notice Original Award Notice

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity